ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 695,78
0,83%
Dow Jones
39 308,00
-0,06%
DAX
18 450,48
0,38%
Brent Oil
87,265
0,41%
Bitcoin
58 212,41
-3,24%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Vascular Biogenics Ltd (VBLT)

  7. Vascular Biogenics Ltd (VBLT) Actualités

VBLT

Vascular Biogenics (VBLT)

Vascular Biogenics Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:VBLT
DateHeureSourceTitreSymboleSociété
01/07/202423h19Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
20/06/202423h01Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:VBLTVascular Biogenics Ltd
10/05/202423h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
06/05/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
19/04/202422h56Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VBLTVascular Biogenics Ltd
11/04/202423h00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VBLTVascular Biogenics Ltd
01/04/202422h30Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:VBLTVascular Biogenics Ltd
16/02/202415h00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VBLTVascular Biogenics Ltd
05/02/202423h00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VBLTVascular Biogenics Ltd
11/01/202423h22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
08/01/202422h21Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:VBLTVascular Biogenics Ltd
29/11/202323h15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
26/10/202323h15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
26/10/202323h15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:VBLTVascular Biogenics Ltd
19/10/202319h34Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:VBLTVascular Biogenics Ltd
17/10/202323h01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VBLTVascular Biogenics Ltd
10/10/202314h01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:VBLTVascular Biogenics Ltd
02/10/202323h29Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VBLTVascular Biogenics Ltd
06/09/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VBLTVascular Biogenics Ltd
05/09/202321h52Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
14/08/202314h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VBLTVascular Biogenics Ltd
09/06/202322h32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:VBLTVascular Biogenics Ltd
15/05/202322h46Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VBLTVascular Biogenics Ltd
15/05/202322h11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VBLTVascular Biogenics Ltd
18/04/202322h37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VBLTVascular Biogenics Ltd
14/03/202313h02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VBLTVascular Biogenics Ltd
09/12/202223h15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:VBLTVascular Biogenics Ltd
18/11/202212h15TipRanksH.C. Wainwright Reaffirms Their Hold Rating on Vascular Biogenics (VBLT)NASDAQ:VBLTVascular Biogenics Ltd
20/07/202214h55TipRanksVascular Biogenics (VBLT) Receives a Hold from JonesTradingNASDAQ:VBLTVascular Biogenics Ltd
20/07/202212h15TipRanksAnalysts Offer Insights on Healthcare Companies: Celsion (CLSN), Vascular Biogenics (VBLT) and Portage Biotech Inc (PRTG)NASDAQ:VBLTVascular Biogenics Ltd
 Showing the most relevant articles for your search:NASDAQ:VBLT

Dernières Valeurs Consultées

NASDAQ
AAPL
Apple
FTSE
UKX
FTSE 100
NASDAQ
NVDA
NVIDIA
NASDAQ
MSFT
Microsoft
EU
VK
Vallourec
EU
MC
Lvmh Moet Hennessy Louis...
EU
CS
Axa
EU
PX4
SBF 120
EU
DG
Vinci
EU
ML
Michelin
COIN
BTCUSD
Bitcoin
EU
CAP
Capgemini
NYSE
NKE
Nike
EU
EN
Bouygues
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés